I. Vonkugelgen et al., EVIDENCE FOR P-2-PURINOCEPTOR-MEDIATED INHIBITION OF NORADRENALINE RELEASE IN RAT-BRAIN CORTEX, British Journal of Pharmacology, 113(3), 1994, pp. 815-822
1 Some postganglionic sympathetic axons possess P-2y-like P-2-purinoce
ptors which, when activated, decrease the release of noradrenaline. We
examined the question of whether such receptors also occur at the nor
adrenergic axons in the rat brain cortex. Slices of the brain cortex w
ere preincubated with [H-3]-noradrenaline, then superfused with medium
containing desipramine (1 mu M) and stimulated electrically, in most
experiments by trains of 4 pulses/100 Hz. 2 The selective adenosine A(
1)-receptor agonist, N-6-cyclopentyl-adenosine (CPA; 0.03-3 mu M) as w
ell as the non-subtype-selective agonist 5'-N-ethylcarboxamido-adenosi
ne (NECA; 0.3-3 mu M) reduced the evoked overflow of tritium, whereas
the adenosine A(2a)-receptor agonist, yl)-phenethylamino-5'-N-ethylcar
boxamido-adenosine (CGS-21680; 0.003-30 mu M) and the adenosine A(3)-r
eceptor agonist N-6-2-(4-aminophenyl)ethyl-adenosine (APNEA; 0.03-3 mu
M) caused no change. Of the nucleotides tested, ATP (30-300 mu M), ad
enosine-5'-O-(3-thiotriphosphate) (ATP gamma S; 30-300 mu M), adenosin
e-5'-O-(2-thiodiphosphate) (ADP beta S; 30-300 mu M), P-1,P-4-di(adeno
sine-5')-tetraphosphate (Ap(4)A; 30-300 mu M) and the preferential P-2
Y-purinoceptor agonist, 2-methylthio-ATP (300 mu M) decreased the evok
ed overflow of tritium. The P-2X-purinoceptor agonist, alpha,beta-meth
ylene-ATP (3-300 mu M) caused no change. 3 The A(1)-selective antagoni
st, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX; 10 nM) attenuated the e
ffects of the nucleosides CPA (apparent pK(B) value 9.8) and NECA as w
ell as of the nucleotides ATP (apparent pK(B) 9.3), ATP gamma S (appar
ent pK(B) 9.2) and ADP beta S (apparent pK(B) 8.7). CGS-21680 and APNE
A were ineffective also in the presence of DPCPX. The A(2)-selective a
ntagonist -dipropyl-8-(3,4-dimethoxystyryl)-7-methylxanthine (KF-17837
) reduced the effects of CPA, NECA and ATP gamma S only when given at
a concentration of 300 nM but not at 10 nM. 4 The P-2-purinoceptor ant
agonists, suramin (300 mu M), reactive blue 2 (30 mu M) and cibacron b
lue 3GA (30 mu M) did not change the effect of CPA. Suramin and cibacr
on blue 3GA shifted the concentration-response curve of ATP gamma S to
the right (apparent pK(B) values 3.7 and 5.0, respectively). Reactive
blue 2 also attenuated the effect of ATP gamma S, and cibacron blue 3
GA attenuated the effect of ATP, but in these cases the agonist concen
tration-response curves were not shifted to the right. There was no an
tagonistic effect of suramin against ATP and ADP beta S. 5 The results
indicate that rat cerebrocortical noradrenergic axons possess, in add
ition to the known adenosine A(1)-receptor, a separate purinoceptor fo
r nucleotides (P-2) which, in contrast to the A(1)-receptor, is blocke
d by suramin, reactive blue 2 and cibacron blue 3GA. Nucleotides such
as ATP and ATP gamma S activate both receptors. Inconsistencies in ant
agonist effects against nucleotides are probably due to this activatio
n of two receptors. The presynaptic P-2-purinoceptor is P-2Y-like, as
it is in the peripheral sympathetic nervous system.